conference paper · 2012

Combined formulation of Doxorubicin-Arg-Gly-Asp (RGD) and modified PEGylated PLGA-encapsulated nanocarrier improves anti-tumor activity

Citations: 4from other works
Field-weighted impact: 0.001.00 is the world average for its field and year
Among its field: 20th percentileby citations, against works of its field and year
Authors: 3from 3 institutions

Authors

3 authors across 3 institutions in 3 countries

A work can sit in several, each with a score